World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
9665
World Ranking
3987
National Ranking
150

Suzanne Jurriaans publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Suzanne Jurriaans sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 157 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Suzanne Jurriaans D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Suzanne Jurriaans sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 54 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Suzanne Jurriaans is affiliated with the University of Amsterdam in the Netherlands and has contributed extensively to the field of Medicine, with a particular focus on Infectious Diseases, Modeling and Simulation, Virology, Health, and Epidemiology.

Their research topics encompass:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • Vaccine Coverage and Hesitancy
  • HIV/AIDS drug development and treatment

Jurriaans has published in several scientific venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet Regional Health - Europe
  • AIDS
  • Epidemiology and Infection
  • JCI Insight

Frequent co-authors in their publications are:

  • Janke Schinkel
  • Anders Boyd
  • Maria Prins
  • Jan M. Prins
  • Marc van der Valk

Among recent papers, several are notable for their contribution to infectious disease research:

  • "Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART" (2020, JCI Insight)
  • "HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study" (2020, The Lancet HIV)
  • "Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers" (2021, JAMA Network Open)
  • "Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study" (2021, The Lancet Regional Health - Europe)
  • "CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency" (2020, Cell Reports)

Best Publications

  • Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

    Marieke Den Brinker;Ferdinand W.N.M. Wit;Pauline M.E. Wertheim-van Dillen;Suzanne Jurriaans

  • Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy

    Ferdinand W. N. M. Wit;Gerrit Jan Weverling;Jan Weel;Suzanne Jurriaans

  • Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission

    Thijs J.W. Van De Laar;Akke K. Van Der Bij;Maria Prins;Sylvia M. Bruisten

  • Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

    J.M. Prins;S. Jurriaans;van R.M.E. Praag;H. Blaak

  • Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.

    Hanneke Borgdorff;Evgeni Tsivtsivadze;Rita Verhelst;Massimo Marzorati

  • Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine

    D W Notermans;S Jurriaans;F de Wolf;N A Foudraine

  • High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.

    S Kostense;G S Ogg;E H Manting;G Gillespie

  • The Natural History of HIV-1 Infection: Virus Load and Virus Phenotype Independent Determinants of Clinical Course?

    Suzanne Jurriaans;Bob Van Gemen;Gerrit Jan Weverling;Dianne Van Strup

  • Outcome and Predictors of Failure of Highly Active Antiretroviral Therapy: One-Year Follow-Up of a Cohort of Human Immunodeficiency Virus Type 1-Infected Persons

    Ferdinand W. N. M. Wit;Remko van Leeuwen;Gerrit Jan Weverling;Suzanne Jurriaans

  • OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

    R. M. E. Van Praag;J. M. Prins;M. T. L. Roos;P. Th. A. Schellekens

  • Emergence of a Drug-Dependent Human Immunodeficiency Virus Type 1 Variant during Therapy with the T20 Fusion Inhibitor

    Chris E. Baldwin;Rogier W. Sanders;Yiqun Deng;Suzanne Jurriaans

  • Longitudinal Phenotypic Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes: Correlation with Disease Progression

    Graham S. Ogg;Stefan Kostense;Michel R. Klein;Suzanne Jurriaans

  • Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study

    Monique He Reijers;Gerrit Jan Weverling;Suzanne Jurriaans;Ferdinand Wnm Wit

  • Predictors for Non- and Slow Progression in Human Immunodeficiency Virus (HIV) Type 1 Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-1 p24-Specific but Not V3-Specific Antibody Levels

    E. Hogervorst;S. Jurriaans;F. de Wolf;A. van Wijk

  • Highly Sensitive Methods Based on Seminested Real-Time Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 Unspliced and Multiply Spliced RNA and Proviral DNA

    Alexander O. Pasternak;Karen W. Adema;Margreet Bakker;Suzanne Jurriaans

  • The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

    R. M. W. Hoetelmans;M. H. E. Reijers;G. J. Weverling;R. W. Ten Kate

  • Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

    Charlotte H. S. B. van den Berg;Colette Smit;Margreet Bakker;Ronald B. Geskus

  • Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study

    Irálice A V Jansen;Ronald B Geskus;Udi Davidovich;Suzanne Jurriaans

  • Sources of HIV infection among men having sex with men and implications for prevention

    Oliver Ratmann;Ard van Sighem;Daniela Bezemer;Alexandra Gavryushkina

  • The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

    Pillay D;Bhaskaran K;Jurriaans S;Prins M

  • Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

    Gerrit J. Weverling;Joep M.A. Lange;Suzanne Jurriaans;Jan M. Prins

Frequent Co-Authors

Jan M. Prins
Jan M. Prins University of Amsterdam
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Ben Berkhout
Ben Berkhout University of Amsterdam
Jaap Goudsmit
Jaap Goudsmit Harvard University
Hanneke Schuitemaker
Hanneke Schuitemaker Valneva (Austria)
Peter Reiss
Peter Reiss University of Amsterdam
Frank Miedema
Frank Miedema Utrecht University
Maria Prins
Maria Prins University of Amsterdam
Georgios Pollakis
Georgios Pollakis University of Liverpool
F. de Wolf
F. de Wolf Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees and careers can open diverse opportunities. Many professionals expanding their skills consider programs like the easiest mph online programs to get into, which offer a gateway to public health roles that complement microbiological expertise.

Career options extend beyond laboratory work. For example, becoming a child life specialist merges science with patient care and emotional support, with promising earning potential. This path emphasizes communication skills in healthcare settings, beneficial for those with a microbiology background.

Additionally, those facing challenges re-entering the workforce can benefit from exploring the best degree for felons options, which include accessible online programs. These degrees can provide a fresh start in scientific or healthcare fields, emphasizing inclusivity and second chances.

Another growing field is functional medicine, where specialized knowledge is essential. Programs such as functional medicine nurse practitioner programs prepare graduates for integrative healthcare roles that incorporate microbiological insights with holistic patient care.

Best Scientists Citing Suzanne Jurriaans

Trending Scientists

Recently Published Articles